A Study of Barzolvolimab in Patients With Prurigo Nodularis
Clinical trial NCT06366750 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06366750
- Sponsor
- Celldex Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-12
- Primary completion
- 2026-03-17
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.